Hybridoma technology Flashcards
who founded hybridoma technology
George Kohler and Cesar Milstein
George Kohler and Cesar Milstein won the
nobel prize in physiology of medicine in 1984
aim of hybridoma technology
to produce monoclonal antibodies
hybridoma technology allows
the identification and culture of cells secretion identical antibodies with pre-defined specificity
basic mechanism of hybridoma technology
A single clone of cells secreting a single
antibody is made by fusing a B cell (Ig+ splenocyte
with finite lifespan) with a myeloma cell (cancerous
Ig- B cell with infinite lifespan)
The resulting hydrid cells (HYBRIDOMAS) each
make a specific monoclonal antibody
B cells
Ig+ splenocyte with finite lifespan
myeloma cell
cancerous, Ig- B cell with infinite lifespan
hybridisation process takes how many injection of specific antigen?
4
the 4 injections cause
antibody switching, meaning antibodies become more and more specific to the antigen
- affinity increasing as immunisation continues
Hybridisation process
1) inject mice with antigen of interest (directly into spleen)
2) antigen goes into blood stream and activates B cells
3) within first few days activation of multivalent IgMs
4) as immunising continues (every 2 week) the immune response builds up: IgM- IgG
5) then blood serum retrieved from mouse by cutting tail
6) serum tested for response to target antigen
7) if response large enough, the mouse it euthanised and spleens removed
8) B cells isolated for hybridisation
9) spleen B cell (splenocyte) fused with myeloma cells in vitro
10) left with a mixture of useful hybrid cells and un-useful unfused myeloma and splenocytes
within the first few days
activation of multivalent IgMs
how long between each injection
2 weeks
IgG
best form of antibody for therapy and diagnostics
splenocyte
spleen B cell
myeloma
cancer cells which are immortalised and Ig-
what is used to isolate hybrid cells
HAT medium